Pseudoprotodioscin

Overview

Pseudoprotodioscin, a furostanoside, inhibits SREBP1/2 and microRNA 33a/b levels and reduces the gene expression regarding the synthesis of cholesterol and triglycerides.

Application

Products | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Obesity | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Fatty Acid Synthase (FASN) | Products > Signaling Pathways > MicroRNA

Product Information

• Catalog No.: HY-N0686
• CAS No.: 102115-79-7
• Molecular Formula: C51H82O21
• Molecular Weight: 1031.18
• Purity: 99.17%
• Storage: -20°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (2.42 mM); Clear solution
• Availability: In-stock

Source

Original product source